Evidence map›Paper›PMID 37101024›Full record

ArticleWiener klinische Wochenschrift2023

[Injection therapy of diabetes].

Monika Lechleitner, Michael Roden, Raimund Weitgasser, Bernhard Ludvik, Peter Fasching, Friedrich Hoppichler, Alexandra Kautzky-Willer, Guntram Schernthaner, Rudolf Prager, Susanne Kaser and 2 more

Open access · hybridAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Monika LechleitnerAvomed-Arbeitskreis für Vorsorgemedizin und Gesundheitsförderung in Tirol, Innsbruck, Österreich.
Michael RodenKlinik für Endokrinologie und Diabetologie, Medizinische Fakultät, Heinrich-Heine-Universität, Düsseldorf, Deutschland.
Raimund WeitgasserAbteilung für Innere Medizin, Privatklinik Wehrle-Diakonissen, Salzburg, Österreich.
Bernhard LudvikMedizinische Abteilung mit Diabetologie, Endokrinologie und Nephrologie, Klinik Landstraße, Wien, Österreich.
Peter FaschingMedizinische Abteilung für Endokrinologie, Rheumatologie und Akutgeriatrie, Wilhelminenspital der Stadt Wien, Wien, Österreich.
Friedrich HoppichlerAbteilung für Innere Medizin, Krankenhaus der Barmherzigen Brüder Salzburg, Salzburg, Österreich.
Alexandra Kautzky-WillerGender Medicine Unit, Klinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Spitalgasse 23, 1090, Wien, Österreich. alexandra.kautzky-willer@meduniwien.ac.at.
Guntram SchernthanerDepartment of Internal Medicine II, Medizinische Universität Wien, Wien, Österreich.
Rudolf PragerStoffwechselzentrum im Rudolfinerhaus, Rudolfinerhaus Privatklinik, Wien, Österreich.
Susanne KaserDepartment für Innere Medizin 1, Medizinische Universität Innsbruck, Innsbruck, Österreich.
T C WascherMedizinische Abteilung, Hanusch-Krankenhaus, Wien, Österreich.
Ausschuss Leitlinien
Medical University of Vienna · ATAustrian Competence Centre of Food Safety · ATDeutsches Diabetes-Zentrum e.V. · DEHanusch Hospital · ATInnsbruck Medical University · ATOrdensklinikum Linz Barmherzige Schwestern · ATParacelsus Medical University · ATRudolfinerhaus Hospital · ATWilhelminen Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present article is a recommendation of the Austrian Diabetes Association for the practical use of injection therapy (GLP1-receptor agonists and insulin) in type 2 diabetes.

Indexed as

Diabetes Mellitus, Type 2AustriaHumansHypoglycemic AgentsInsulinHypoglycemic AgentsInsulinInjection therapy and type 2 diabetes mellitus

Identifiers

PMID37101024
PMCPMC10133050
OpenAlexW4367162890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.